KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ionis Pharmaceuticals (IONS) Change in Intangibles (2020 - 2025)

Historic Change in Intangibles for Ionis Pharmaceuticals (IONS) over the last 6 years, with Q3 2025 value amounting to $1.7 million.

  • Ionis Pharmaceuticals' Change in Intangibles rose 11301.96% to $1.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.8 million, marking a year-over-year increase of 10635.21%. This contributed to the annual value of $5.1 million for FY2024, which is 2032.81% up from last year.
  • Per Ionis Pharmaceuticals' latest filing, its Change in Intangibles stood at $1.7 million for Q3 2025, which was up 11301.96% from $2.0 million recorded in Q2 2025.
  • In the past 5 years, Ionis Pharmaceuticals' Change in Intangibles ranged from a high of $14.0 million in Q2 2024 and a low of -$12.8 million during Q3 2024
  • In the last 5 years, Ionis Pharmaceuticals' Change in Intangibles had a median value of $1.2 million in 2024 and averaged $1.3 million.
  • Within the past 5 years, the most significant YoY rise in Ionis Pharmaceuticals' Change in Intangibles was 122205.47% (2024), while the steepest drop was 125909.09% (2024).
  • Quarter analysis of 5 years shows Ionis Pharmaceuticals' Change in Intangibles stood at $1.5 million in 2021, then plummeted by 41.69% to $867000.0 in 2022, then fell by 8.65% to $792000.0 in 2023, then surged by 221.59% to $2.5 million in 2024, then crashed by 34.83% to $1.7 million in 2025.
  • Its last three reported values are $1.7 million in Q3 2025, $2.0 million for Q2 2025, and $651000.0 during Q1 2025.